PrEPVacc
PrEP Vacc Registration Cohort Get Involved Contact Member's Area
Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive
Partners Organisation and Governance Our Funders FAQs
PrEPVaccRegistration CohortGet Involved News Latest News News by partner In the Media Journal Publications List Research Dissemination News Archive About Partners Organisation and Governance Our Funders FAQs ContactMember's Area
PrEPVacc
An African-led, European-supported HIV prevention project running in four countries in East and Southern Africa from 2018 to 2024
 

In the Media

PrEPVacc in the news

Featured
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
Media
Media coverage of PrEPVacc's July 2024 vaccine result announcement
23 July 2024
Media
23 July 2024
Media
Media coverage of PrEPVacc's December 2023 study update
7 December 2023
Media
Media coverage of PrEPVacc's December 2023 study update
7 December 2023
Media
7 December 2023
Media
STAT: 'Can the world still invent an HIV vaccine? Progress in one area creates new problem'
2 October 2023
Media
STAT: 'Can the world still invent an HIV vaccine? Progress in one area creates new problem'
2 October 2023
Media
2 October 2023
Media
CNN reports on ‘the last roll of the dice’ for an HIV vaccine this decade
27 August 2023
Media
CNN reports on ‘the last roll of the dice’ for an HIV vaccine this decade
27 August 2023
Media
27 August 2023
Media
Getty photographer visits PrEPVacc site at Masaka
25 March 2022
Media
Getty photographer visits PrEPVacc site at Masaka
25 March 2022
Media
25 March 2022
Media
PrEPVacc featured in December 2021 'Science et Vie' magazine cover story
23 December 2021
Media
PrEPVacc featured in December 2021 'Science et Vie' magazine cover story
23 December 2021
Media
23 December 2021
Media
‘African scientists should lead in developing an Aids jab for Africa’
1 December 2021
Media
‘African scientists should lead in developing an Aids jab for Africa’
1 December 2021
Media
1 December 2021
Media
Activists push for continuity of HIV vaccine research
23 September 2021
Media
Activists push for continuity of HIV vaccine research
23 September 2021
Media
23 September 2021
Media
Deutsche Welle: ‘After COVID, can researchers speed things up for HIV?’
19 July 2021
Media
Deutsche Welle: ‘After COVID, can researchers speed things up for HIV?’
19 July 2021
Media
19 July 2021
Media
‘Uganda volunteers in phase III of HIV vaccine efficacy trials’ - The East African reports on start of PrEPVacc
21 December 2020
Media
‘Uganda volunteers in phase III of HIV vaccine efficacy trials’ - The East African reports on start of PrEPVacc
21 December 2020
Media
21 December 2020
Media
 

03-Yellow_EDCTP.png
flag_yellow_low.jpg
 

This project is part of the EDCTP2 Programme supported by the European Union

 
prepvacc@gmail.com
Hours
Featured
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
MUHAS Newsletter: HIV vaccines in PrEPVacc trial fail to reduce infections: Results announced at AIDS 2024 conference
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc Vaccine Trial Results Dissemination to participants in Masaka, Uganda
PrEPVacc meets the media in Masaka
PrEPVacc meets the media in Masaka
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
PrEPVacc Vaccine Results Dissemination at SAMRC Verulam: A Step Towards Hope
Joining the studyFAQs Partners of PrEPVacc
PrEPVacc-logo-reverse-rgb.png
 

Contact: prepvacc@gmail.com | Accessibility

© PrEPVacc Investigators 2026 | All rights reserved